These three companies are healthcare leaders. They treat their shareholders well and offer promising growth prospects at ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Srinivas RaoM.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn Short, Ph.D.

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...

The stock market saw something incredible in 2024, with the “Magnificent 7” tech giants leading the charge and driving a huge ...

Small-cap healthcare stocks offer a unique opportunity for investors looking to capitalize on innovation and high growth.

As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up to $27.5m.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Iluzanebart is under clinical development by Vigil Neuroscience and currently in Phase I for Unspecified Neurologic Disorders.

At CES 2025, Earable Neuroscience introduces FRENZ Brainband's Brainwaves Research platform for pharmas and universities collaborations. Kieu My Doan Earable Inc +1 310-686-8168 email us here Visit us ...

The Consumer Technology Association (CTA) honors Earable® Neuroscience with a CES 2025 Innovation Awards® in Digital Health, ...